Showing results (71-80 of 94) with videos related to
Sort By:
Pageof 10
International Clinical Psychopharmacology|January 12, 2010
Psychometric evaluation of a Patient-Rated Most Troubling Symptom Scale for Depression: findings from a secondary analysis of a clinical trialGahan J Pandina, Georges M Garibaldi, Dennis A Revicki, et al.Journal of Clinical Psychopharmacology|September 4, 2010
Paliperidone extended-release in schizoaffective disorder: a randomized, controlled study comparing a flexible dose with placebo in patients treated with and without antidepressants and/or mood stabilizersCarla M Canuso, Nina Schooler, Jennifer Carothers, et al.The Journal of Clinical Psychiatry|April 21, 2004
Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepamGlenn W Currier, James C-Y Chou, David Feifel, et al.Annals of Internal Medicine|November 3, 2007
Risperidone for treatment-refractory major depressive disorder: a randomized trialRamy A Mahmoud, Gahan J Pandina, Ibrahim Turkoz, et al.Journal of Affective Disorders|March 27, 2009
Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trialGahan J Pandina, Dennis A Revicki, Leah Kleinman, et al.Schizophrenia Research. Cognition|September 16, 2022
Dispersion of cognitive performance test scores on the MATRICS Consensus Cognitive Battery: A different perspectiveDavid J Williamson, Keith H Nuechterlein, Todd Tishler, et al.BMJ Open|June 16, 2026
Efficacy and safety of long-acting injectable paliperidone palmitate 1-month and 3-month formulations in the maintenance treatment of schizophrenia: a single-arm, open-label, interventional study in Rwandan healthcare settingsRutakayile Bizoza, Jordy Mehawej, Emmanuel Musoni-Rwililiza, et al.The International Journal of Neuropsychopharmacology|April 10, 2020
Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 DataMichel Nijs, Ewa Wajs, Leah Aluisio, et al.The Journal of Clinical Psychiatry|September 13, 2006
A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorderGeorge M Simpson, Ramy A Mahmoud, Robert A Lasser, et al.Acta Psychiatrica Scandinavica|November 29, 2020
Clinically meaningful changes on depressive symptom measures and patient-reported outcomes in patients with treatment-resistant depressionIbrahim Turkoz, Larry Alphs, Jaskaran Singh, et al.Pageof 10